دور البروموكريبتين في احداث الاباضة لدى مريضات فرط برولاكتين الدم

The study was carried out in the Department of Obstetrics and Gynecology at Alassad University Hospital in Lattakia from 1/1/2003 to 31/6/2004. The study included 65 patients between 18 – 40 years and the results were : Number of hyperprolactinemia patients within the age from 26 – 35 years is 39 patients (60%). Number of hyperprolactinemia in ladies who had pregnancy previously is 44 patients (67.69%). Number of galactorrhea patients is 53 ,out of which blood prolactin was high in 26 patients (49,06%) . Number of hyperprolactinemia patients is 38 , out of which 26 patients suffered from galactorrhea (68,24%). We used vaginal ultrasound and basal body temprature in ovulation detection . The number of patients who had ovulation without needing therapy by bromocriptin was 27 (41.54%). The number of patients who did not have ovulation and who needed therapy by bromocriptin was 38 (58.46%) . Therapy by bromocriptin was applied ( 2.5 -7.5 mg daily three doses ) in 38 patients for three cycles as The patient needed with monitoring ovulation monthly. 30 patients had ovulation (78.95%), and 8 patients failed (21.05%). The number of therapeutic cycles by bromocriptin was 77 cycles. Side effects of bromocriptin were : orthostatic hypotension 8 patients (12.05%), nausae 7 patients (18.42%), vomiting 5 patients (13.16%), headache 4 patients (10.53%), gastric